BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14639122)

  • 21. Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas.
    Yu HA; Sima CS; Hellmann MD; Naidoo J; Busby N; Rodriguez K; Riely GJ; Kris MG
    Cancer; 2015 Jun; 121(12):2078-82. PubMed ID: 25781862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple primary malignancies involving lung cancer-clinical characteristics and prognosis.
    Liu YY; Chen YM; Yen SH; Tsai CM; Perng RP
    Lung Cancer; 2002 Feb; 35(2):189-94. PubMed ID: 11804692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancer among women in France. Analysis of the 904 French women with lung cancer included in the KBP-2000-CPHG study of the French College of General Hospital-based Pneumologists (CPHG).
    Grivaux M; Breton JL; Bombaron P; Kuntz P; Lebas FX; Mehdaoui A; Herman D; David P; Berruchon J; Delclaux B; Zureik M; Blanchon F;
    Lung Cancer; 2004 Sep; 45(3):279-87. PubMed ID: 15301868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends and Outcomes of Non-Small-Cell Lung Cancer in Omani Patients: Experience at a university hospital.
    Furrukh M; Kumar S; Zahid KF; Al-Shamly HS; Al-Jabri ZA; Burney IA; Al-Moundhri MS
    Sultan Qaboos Univ Med J; 2017 Aug; 17(3):e301-e308. PubMed ID: 29062552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-small cell lung cancer: surgical trends as a function of age].
    Riquet M; Medioni J; Manac'h D; Dujon A; Souilamas R; Le Pimpec Barthes F; Hubsch JP
    Rev Mal Respir; 2001 Apr; 18(2):173-84. PubMed ID: 11424713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and clinicopathologic features of primary lung cancer: a North-Eastern Anatolia region study in Turkey (2006-2012).
    Demirci E; Daloglu F; Gundogdu C; Calik M; Sipal S; Akgun M
    Asian Pac J Cancer Prev; 2013; 14(3):1989-93. PubMed ID: 23679305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The EpicliCP-2003 study: A multicenter epidemiological and clinical study of lung cancer in Spain].
    Sánchez de Cos Escuín J; Miravet Sorribes L; Abal Arca J; Núñez Ares A; Hernández Hernández J; Castañar Jover AM; Muñoz Gutiérrez FJ; García Arangüena L; Alonso MA; Montero Martínez MC; Allende González J; Sánchez Hernández I
    Arch Bronconeumol; 2006 Sep; 42(9):446-52. PubMed ID: 17040660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
    Birim O; Kappetein AP; Bogers AJ
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in lung cancer histological types in Varese Cancer Registry, Italy 1976-1992.
    Russo A; Crosignani P; Franceschi S; Berrino F
    Eur J Cancer; 1997 Sep; 33(10):1643-7. PubMed ID: 9389928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resection rate of lung cancer in Teesside (UK) and Varese (Italy): a comparison after implementation of the National Cancer Plan.
    Imperatori A; Harrison RN; Dominioni L; Leitch N; Nardecchia E; Jeebun V; Brown J; Altieri E; Castiglioni M; Cattoni M; Rotolo N
    Thorax; 2016 Mar; 71(3):230-7. PubMed ID: 26612687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional and national variation in lung cancer mortality in Italy and Czechoslovakia.
    Kubík A; Bonassi S; Filiberti R; Reissigová J
    Eur J Cancer Prev; 1993 Jul; 2(4):337-44. PubMed ID: 8358286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).
    Ferrigno D; Buccheri G; Giordano C
    Lung Cancer; 2003 Sep; 41(3):311-20. PubMed ID: 12928122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
    Bryant A; Cerfolio RJ
    Chest; 2007 Jul; 132(1):185-92. PubMed ID: 17573517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
    Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
    J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
    Cerfolio RJ; Bryant AS; Scott E; Sharma M; Robert F; Spencer SA; Garver RI
    Chest; 2006 Dec; 130(6):1796-802. PubMed ID: 17166999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung cancer screening in cigarette smokers in the province of Varese, Italy.
    Dominioni L; Imperatori A; Rovera F; Ochetti A; Paolucci M; Dionigi G
    Cancer; 2000 Dec; 89(11 Suppl):2345-8. PubMed ID: 11147609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer in patients with HIV-infection.
    Vyzula R; Remick SC
    Lung Cancer; 1996 Nov; 15(3):325-39. PubMed ID: 8959678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer.
    Yoshida Y; Murayama T; Sato Y; Suzuki Y; Saito H; Nomura Y
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):507-14. PubMed ID: 26366891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time trends of lung cancer incidence by histologic types and smoking prevalence in Hong Kong 1983-2000.
    Au JS; Mang OW; Foo W; Law SC
    Lung Cancer; 2004 Aug; 45(2):143-52. PubMed ID: 15246184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.